Emmanuel Krakaris

This profile gathers the share dealings of Emmanuel Krakaris in Augmedix, Inc., where the filings describe the role as chief executive. In total, 7 filings cover trades dated from 28 October 2021 to 2 October 2024.

The open-market side counts 2 purchases for €173k alongside 1 sale for €3,855. The net balance comes to €169k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant and 2 option exercises. 2024 to date brings no purchases and 1 sale.

Most recently, on 4 October 2024, the filings show a transaction worth €138k in Augmedix, Inc. The last purchase on record was published on 24 November 2021, which is 1,795 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.